Consuming this diet may boost bones density in postmenopausal women

A new study suggests that postmenopausal women should consume a Mediterranean diet as it may boost their bones and muscle mass.

Consuming this diet may boost bones density in postmenopausal women
Representational image

Rio de Janeiro: A new study suggests that postmenopausal women should consume a Mediterranean diet – that is rich in fruits, vegetables, grains, potatoes, olive oil, seeds, fish, low saturated fat, dairy products and red meat as it may boost their bones and muscle mass.

Researchers found that menopause -- characterised by a decline in estrogen levels -- speeds a woman's loss of bone mass and increases her risk of developing the bone-thinning disease known as osteoporosis, and increases the risk of fractures.

Thais Rasia Silva, a postdoctoral student at Universidade Federal do Rio Grande do Sul in Brazil said,"We found that the Mediterranean diet could be a useful non-medical strategy for the prevention of osteoporosis and fractures in postmenopausal women."

Silva added,"Postmenopausal women, especially those with low bone mass, should ask their doctor whether they might benefit from consuming this dietary pattern."

The study also linked the Mediterranean diet with a lower risk of heart disease, diabetes, cancer, and mortality risk due to certain other chronic diseases.

For the study, the team included 103 healthy women with an average age of 55 and who had gone through menopause 5.5 years earlier, on an average.

All women underwent bone scans to measure their bone mineral density, total body fat and appendicular lean mass, which was used to estimate skeletal muscle mass. They also completed a food questionnaire about what they ate in the past month.

The findings showed that a higher consumption of Mediterranean diet was associated with an increased bone mineral density measured at the lumbar spine and with greater muscle mass.

The previous studies have found that the Mediterranean diet may also boost conception chances of women undergoing in-vitro fertilisation (IVF).

The study was presented at the Endocrine Society's 100th Annual Meeting in Chicago.

(With IANS inputs)

By continuing to use the site, you agree to the use of cookies. You can find out more by clicking this link

Close